Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer ...
A 20-year-old woman with large bilateral ovarian masses was diagnosed with B-lymphoblastic leukemia after lymph-node and bone ...
In a phase 1 trial, CD19/CD20/CD22 CAR T cells produced complete responses in 83% of patients with relapsed/refractory B-cell ...
A cross-sectional study shows that ocrelizumab selectively contracts EBV-specific CD4 T-cell immunity in multiple sclerosis ...
Results from a phase I clinical trial led by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer ...
A phase I trial of OX40-enhanced CAR-T therapy showed remissions in several B-cell non-Hodgkin lymphomas, researchers ...
Children with B-cell acute lymphoblastic leukemia may experience adverse family outcomes related to household changes and family functioning.
B-cell lymphoma is a type of non-Hodgkin lymphoma. It’s also the most common type of lymphoma. Approximately 85% of all lymphomas in the United States are B-cell lymphomas. Non-Hodgkin lymphomas are ...
Why do outcomes differ even when patients receive the same treatment?Even when patients are diagnosed with the same condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results